Related Experiment Videos
Steroid-dependent nephrotic syndrome with minimal glomerular changes and mesangial IgA deposits
Child Nephrology and Urology
|January 1, 1988
Abstract:
We report 3 children with steroid-dependent nephrotic syndrome, without hematuria. The renal biopsies showed minimal-change disease with mesangial IgA deposits. Their clinical presentation and therapeutic responses were similar to our cases of biopsied nephrotic syndrome with minimal glomerular abnormalities. We believe that our cases have minimal-change disease and not Berger's disease with nephrotic syndrome.
Insights
Three children with steroid-dependent nephrotic syndrome were diagnosed with minimal-change disease, despite mesangial IgA deposits. This finding distinguishes it from Berger
Area of Science:
- Nephrology
- Pediatric Nephrology
- Immunopathology
Background:
- Steroid-dependent nephrotic syndrome (SDNS) is a common cause of kidney disease in children.
- Distinguishing minimal-change disease (MCD) from IgA nephropathy (e.g., Berger's disease) is crucial for prognosis and treatment.
- Mesangial IgA deposits can be present in various glomerular diseases, complicating diagnosis.
Observation:
- This study reports on three children presenting with SDNS but lacking hematuria.
- Renal biopsies revealed minimal-change disease morphology.
- Interestingly, mesangial IgA deposits were observed in the glomeruli of these patients.
Findings:
- The clinical presentation and response to therapy in these patients were consistent with MCD.
- Despite the presence of IgA deposits, the overall picture pointed towards MCD rather than Berger's disease.
- This suggests that mesangial IgA deposits may not always indicate IgA nephropathy in the context of SDNS.
Implications:
- These findings challenge the traditional diagnostic criteria for differentiating MCD and IgA nephropathy.
- It highlights the importance of considering MCD even in the presence of mesangial IgA deposits, especially in children with SDNS and no hematuria.
- Further research is needed to understand the role of IgA deposits in MCD and their impact on disease progression.